ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
G04CA02 | G | Tamsulosin HCl - 0.4mg | 6029 | 222262/08 | TALUSIN | 0.4mg | 30 | Capsule, modified release | Oral | Pharmamedic S.A.R.L. | Mediphar Laboratories | Lebanon | 683,440 L.L | 23.08 | A1 | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
G04CA02 | B | Tamsulosin HCl - 0.4mg | 5468 | 24709/07 | OMNIC OCAS | 0.4mg | 30 | Tablet, film coated, prolonged release | Oral | Mersaco | Astellas Pharma Europe BV | The Netherlands | 866,778 L.L | 23.08 | A2 | Astellas Pharma Europe BV | The Netherlands | 2/5/2024 | 0 |
G04CA02 | G | Tamsulosin HCl - 0.4mg | 7316 | 187401/13 | APO-TAMSULOSIN CR | 0.4mg | 30 | Tablet | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 607,417 L.L | 23.08 | A1 | Apotex Inc | Canada | 2/5/2024 | 0 |
G04CA02 | G | Tamsulosin - 0.4mg | 8589 | 166611/11 | MINGO | 0.4mg | 30 | Capsule | Oral | Medi drug International SAL (MDI) | Pharmadex licensed by Orbucell pharma Canada | Lebanon | 673,201 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
G04CA02 | G | Tamsulosin HCl - 0.4mg | 5087 | 24670/07 | PROSTAFINE | 0.4mg | 30 | Capsule, modified release | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 761,511 L.L | 23.08 | A2 | 2/5/2024 | 0 | ||
G04CA02 | G | Tamsulosin - 0.4mg | 9072 | 66717/1 | TAMSU GENERICON RETARD | 0.4mg | 30 | Capsule, hard, modified release | Oral | Algenericon Med | Synthon Hispania SL | Spain | 615,480 L.L | 23.08 | A1 | Genericon Pharma GmbH | Austria | 2/5/2024 | 0 |